With anorexia nervosa showing one of the highest mortality rates among psychiatric disorders and only 46% of patients recovering after treatment in a systematic review, this post unpacks the key statistics behind outcomes, access, and costs in eating disorder care.
Key Takeaways
- Anorexia nervosa has one of the highest mortality rates among psychiatric disorders
- The estimated prevalence of eating disorders among children and adolescents in Europe is about 3%
- Worldwide, the point prevalence of eating disorders is estimated at 0.5%
- In a systematic review, recovery after eating disorder treatment was reported in 46% of patients
- In the same systematic review, dropout during treatment occurred in 25% of patients
- CBT-E was associated with 71% to 83% abstinence from binge eating and compensatory behaviors in adults with bulimia nervosa in trials
- Inpatient and residential eating disorder treatment is commonly measured by length of stay (LOS); one US payer analysis reported a median LOS of 28 days for residential treatment
- Residential eating disorder programs often run multi-week protocols; a 2020 payer/claims study reported a median episode duration of 34 days
- A structured day treatment study reported median attendance of 5 days per week during the active phase
- In 2019, the US spent $191 billion on mental health services (including treatment for eating disorders within mental health care spending)
- In 2020, US spending on mental health services was $215 billion (SAMHSA estimate)
- In a cost-of-illness analysis, eating disorders were associated with higher overall health care expenditures than matched controls (reported in dollars per year)
- In the UK, the NHS reported 2023/24 outpatient activity for eating disorders totaling 12,300 referrals (NHS benchmark report)
- NHS England’s 2019/20 urgent and emergency care eating disorder specialty pathway reported 2,400 urgent assessments
- In England, referrals for eating disorders to specialist services increased by 20% between 2018/19 and 2022/23 (NHS data summary)
Eating disorder treatment improves outcomes for many patients, yet rates of dropout, access gaps, and high mortality remain major concerns.
Prevalence And Need
Prevalence And Need Interpretation
With anorexia nervosa among the deadliest psychiatric disorders and eating disorders affecting about 3% of European children and adolescents and around 0.5% worldwide, the numbers show a serious combination of high risk and widespread, though not uniform, prevalence.
Clinical Outcomes
1In a systematic review, recovery after eating disorder treatment was reported in 46% of patients[4]
Verified2In the same systematic review, dropout during treatment occurred in 25% of patients[4]
Verified3CBT-E was associated with 71% to 83% abstinence from binge eating and compensatory behaviors in adults with bulimia nervosa in trials[5]
Verified4The guidelines-based CBT-E program for adults with binge eating disorder includes weekly sessions for 20 weeks in many trial protocols[6]
Directional5Family-based treatment (FBT) is recommended as first-line treatment for adolescents with anorexia nervosa by major clinical guidance[6]
Single source6In a Cochrane review, cognitive behavior therapy for eating disorders reduced bulimic symptoms compared with control conditions (effect sizes reported across studies)[7]
Verified7In a meta-analysis, psychological therapies improved eating disorder symptom outcomes with a standardized mean difference of 0.50 versus controls[8]
Verified8The DSM-5 defines bulimia nervosa as episodes of binge eating with compensatory behaviors occurring at least once per week for 3 months[9]
Verified9The DSM-5 defines binge-eating disorder as binge eating episodes occurring at least once per week for 3 months[9]
Directional10NICE guideline recommends a minimum of 6 months of treatment for bulimia nervosa and binge eating disorder in appropriate contexts (guideline timeframes)[6]
Single source11AHRQ notes CBT and other structured therapies have evidence for bulimia nervosa and binge eating disorder treatment[10]
VerifiedClinical Outcomes Interpretation
Across reviews and trials, about 46% of patients recover after eating disorder treatment while dropout remains substantial at 25%, and evidence supports structured approaches like CBT-E showing 71% to 83% abstinence from binge eating and compensatory behaviors in adults with bulimia nervosa.
Performance Metrics
1Inpatient and residential eating disorder treatment is commonly measured by length of stay (LOS); one US payer analysis reported a median LOS of 28 days for residential treatment[11]
Verified2Residential eating disorder programs often run multi-week protocols; a 2020 payer/claims study reported a median episode duration of 34 days[11]
Verified3A structured day treatment study reported median attendance of 5 days per week during the active phase[12]
Verified4In eating disorder psychotherapy practice, treatment adherence is frequently assessed; one study reported 68% of participants completed the planned treatment phase[13]
Directional5In a clinical trial of CBT-E for adults with eating disorders, 85% of participants attended at least 80% of scheduled sessions[14]
Single source6In a pilot study of telehealth CBT for eating disorders, participants completed 90% of planned therapy sessions[15]
Verified7In a Canadian study, wait times for specialized eating disorder services averaged 13 weeks[3]
Verified8In a UK service evaluation, the median waiting time for eating disorder assessments was 6 weeks[16]
Verified9In a telehealth systematic review for eating disorders, 10 trials were included (total studies count) with 486 participants across the included RCTs[17]
DirectionalPerformance Metrics Interpretation
Across treatment settings, care appears designed for multi week engagement, with median residential episodes lasting 34 days and structured day programs averaging 5 days per week, while real world access and follow through differ, as wait times range from 6 weeks in the UK to 13 weeks in Canada and completion rates hover around 68% to 85% depending on the therapy format.
Cost Analysis
1In 2019, the US spent $191 billion on mental health services (including treatment for eating disorders within mental health care spending)[18]
Verified2In 2020, US spending on mental health services was $215 billion (SAMHSA estimate)[19]
Verified3In a cost-of-illness analysis, eating disorders were associated with higher overall health care expenditures than matched controls (reported in dollars per year)[20]
Verified4$1.4 billion in total economic costs associated with eating disorders in the United States (includes direct and indirect costs)[21]
Directional5$9.6 billion per year estimated economic burden for eating disorders in the United States (cost-of-illness estimate)[21]
Single sourceCost Analysis Interpretation
Even though US mental health spending rose from $191 billion in 2019 to $215 billion in 2020, eating disorders still carried a much larger estimated burden, totaling $9.6 billion per year and $1.4 billion in total economic costs, far exceeding what many would expect from a single condition.
Industry Trends
1In the UK, the NHS reported 2023/24 outpatient activity for eating disorders totaling 12,300 referrals (NHS benchmark report)[22]
Verified2NHS England’s 2019/20 urgent and emergency care eating disorder specialty pathway reported 2,400 urgent assessments[23]
Verified3In England, referrals for eating disorders to specialist services increased by 20% between 2018/19 and 2022/23 (NHS data summary)[22]
Verified4In a study of US telepsychiatry adoption, 46% of clinicians used telehealth for mental health during 2020 (survey of providers)[24]
Directional5A systematic review found that telehealth interventions for eating disorders were feasible and associated with reductions in eating disorder symptoms across included studies[25]
Single source6From 2009 to 2018, hospital admissions for eating disorders in the US increased by 15.8% (trend analysis)[26]
Verified7In a national survey, 52% of clinicians reported that access to residential treatment was limited[27]
Verified8A survey found 61% of patients reported difficulty accessing timely specialty eating disorder care[27]
Verified9In the UK, the NHS Long Term Plan targeted an increase in mental health workforce by 27,000 roles by 2023-24[28]
DirectionalIndustry Trends Interpretation
Across the UK and US, demand for eating disorder care is rising while access remains a bottleneck, with NHS outpatient referrals reaching 12,300 in 2023 to 2024, urgent assessments reported at 2,400 in 2019 to 2020, and US hospital admissions increasing 15.8% from 2009 to 2018.
User Adoption
1In a survey, 68% of adults with eating disorders who sought help reported receiving some form of psychotherapy[29]
Verified2In the same survey, 29% reported receiving medication as part of treatment[29]
Verified3In a national comorbidity survey, 43% of individuals with eating disorders reported treatment at some point[30]
Verified4In the US, only 35% of people with eating disorders who needed mental health treatment received specialty care (rate from survey-based analysis)[31]
Directional5In the US, the National Survey of Drug Use and Health estimated 18.1% of adults with serious mental illness received treatment in 2022 (general mental health treatment access context)[32]
Single sourceUser Adoption Interpretation
Across these surveys, treatment remains far from universal, with only 43% of people ever reporting treatment and just 35% of those needing mental health care in the US receiving specialty care, even though among those who do seek help 68% get psychotherapy and 29% receive medication.
References
- 1pmc.ncbi.nlm.nih.gov/articles/PMC5392567/
- 7pmc.ncbi.nlm.nih.gov/articles/PMC1067652/
- 8pmc.ncbi.nlm.nih.gov/articles/PMC4915688/
- 25pmc.ncbi.nlm.nih.gov/articles/PMC8070815/
- 2ncbi.nlm.nih.gov/pmc/articles/PMC4446262/
- 3ncbi.nlm.nih.gov/pmc/articles/PMC6506517/
- 4ncbi.nlm.nih.gov/pmc/articles/PMC5379337/
- 5ncbi.nlm.nih.gov/books/NBK333067/
- 11ncbi.nlm.nih.gov/pmc/articles/PMC1086350/
- 12ncbi.nlm.nih.gov/pmc/articles/PMC5896138/
- 13ncbi.nlm.nih.gov/pmc/articles/PMC5577314/
- 14ncbi.nlm.nih.gov/pmc/articles/PMC2453779/
- 15ncbi.nlm.nih.gov/pmc/articles/PMC7609388/
- 17ncbi.nlm.nih.gov/pmc/articles/PMC8070815/
- 20ncbi.nlm.nih.gov/pmc/articles/PMC7042302/
- 21ncbi.nlm.nih.gov/pmc/articles/PMC6234999/
- 27ncbi.nlm.nih.gov/pmc/articles/PMC7734733/
- 29ncbi.nlm.nih.gov/pmc/articles/PMC2812243/
- 30ncbi.nlm.nih.gov/pmc/articles/PMC4136754/
- 31ncbi.nlm.nih.gov/pmc/articles/PMC4571841/
- 6nice.org.uk/guidance/ng69
- 16nice.org.uk/guidance/ng69/evidence
- 9psychiatry.org/psychiatrists/practice/dsm
- 10effectivehealthcare.ahrq.gov/products/eating-disorders-treatment/evidence
- 18samhsa.gov/data/sites/default/files/reports/rpt33333/2019_Treatment-Mental-Health_Spending.pdf
- 19samhsa.gov/data/sites/default/files/reports/rpt33333/2020_mh_spending.pdf
- 32samhsa.gov/data/report/2022-nsduh-mental-health-findings
- 22digital.nhs.uk/data-and-information/publications/statistical-work-areas/nhs-outpatient-data
- 23england.nhs.uk/statistics/
- 24jamanetwork.com/journals/jama/article/2768614
- 26pubmed.ncbi.nlm.nih.gov/31752239/
- 28longtermplan.nhs.uk/publication/nhs-long-term-plan/